Allergy Shot Market

Allergy Shot Market Study by SLIT Tablets, Oral, and Injections for Allergic Rhinitis, Allergic Asthma, Food Allergy, and Atopic Dermatitis from 2024 to 2034

Analysis of Allergy Shot Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Allergy Shot Market Outlook (2024 to 2034)

The global allergy shot market is expected to reach a valuation of US$ 1.84 billion in 2024 and further expand at a CAGR of 6.1% to end up at US$ 3.34 billion by 2034.

An allergy occurs when the body's immune system reacts too strongly to an exogenous item, such as food, pollen, fur, or dust. During allergy immunotherapy, the body is exposed to small amounts of allergens to stimulate the production of antibodies against them. This therapy is an efficient method to treat allergies by regularly exposing the body to specific allergens in low doses.

  • The World Allergy Organization estimates that currently, 10 to 30 percent of people worldwide suffer from some form of allergy.

Factors such as population growth, industrialization, advancements in healthcare and medicine, and the introduction of new immunotherapeutic treatments are driving the global market for allergy immunotherapy. Recent regulatory approvals, including those for oral dissolvable tablets, are also expected to further expand the market for allergy shots.

Allergy symptoms can range from mild, such as hives or a rash, to more severe symptoms like itching, a runny nose, and watery or red eyes. Treatment options for allergies vary depending on the specific allergen sensitivity of the patient. Over-the-counter medications are available for mild allergies, with antihistamines being commonly used. Decongestants provide short-term relief.

For skin reactions like redness and irritation due to allergies, creams, and lotions are often used. Inflammation caused by an allergic reaction can be reduced with steroid treatments. Natural remedies, over-the-counter pharmaceuticals, and prescription medications are also options for managing seasonal allergies.

Allergy shots decrease sensitivity to allergens. In individuals with allergies, the immune system can overreact to harmless substances. Common triggers include dust mites, mold, pollen, pet dander, and insect venom. Allergy shots expose the body to small, safe doses of these triggers, similar to vaccination, which helps the immune system build tolerance and reduce allergy symptoms over time.

The benefits of allergy shots include better allergy management, reduced long-term treatment needs, and decreased sensitivity to various allergens. These advantages are expected to drive increased demand for allergy shots, contributing to the expansion of the allergy shot market size in the foreseeable future.

Report Attribute Detail
Allergy Shot Market Size (2024E) US$ 1.84 Billion
Forecasted Market Value (2034F) US$ 3.34 Billion
Global Market Growth Rate (2024 to 2034) 6.1% CAGR
Canada Market Growth Rate (2024 to 2034) 6.4% CAGR
China Market Value (2034F) US$ 454 Million
North America Market Share (2024E) 39%
East Asia Market Share (2034F) 23.2%
Key Companies Profiled Circassia; Merck; Allergy Therapeutics; ALK-Abello; Letipharma; HollisterStier Allergy; Aimmune Therapeutics; DBV Technologies; Stallergenes Greer; HAL Allergy Group; Biomay AG.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Why is Demand for Allergy Shots on the Rise Worldwide?

“Increasing Prevalence of Rhinitis Necessitating More Effective Treatments”

  • In 2022, research published in Clinical and Translational Allergy indicated that the global median prevalence rates for NAR, AR, and nonspecific rhinitis were 18.1%, 12.0%, and 29.4%, respectively, with variations observed across different regions.
  • According to the Centers for Disease Control and Prevention's estimates for 2023, approximately 25.7% of American adults aged 18 and over were expected to experience seasonal allergies, encompassing nearly 31.8% of the adult population.

This trend is being mirrored in other countries worldwide, contributing to allergy shot market growth. Over time, the prevalence of rhinitis continues to increase, driven by a rise in allergic conditions and a growing necessity for more effective treatments. This growing market for allergy injections is also influenced by urbanization and changing lifestyles, which contribute to the emergence of new allergic conditions.

Factors such as pollution levels, unhealthy dietary habits, and alcohol consumption can trigger various allergic responses, including food and skin allergies, thereby potentially boosting the demand for allergy shot therapies.

The market for allergy shots remains dynamic, driven by advancements in recombinant immunotherapies, specialized medications, and other factors. Industry players are continually expanding their product portfolios, customer bases, and global presence through strategies like mergers, acquisitions, partnerships, and collaborative initiatives. These efforts enable them to meet evolving customer needs, maintain competitiveness, and foster collective growth.

  • For instance, Nestle Health Science announced in August 2020 its acquisition of Immune Therapeutics' food allergy product line, exemplifying strategic moves aimed at enhancing its market position and addressing growing demands in allergy treatment.

What are the Key Concerns in the Market for Allergy Shots?

“Lengthy Treatment Times Not Favored by Many”

Allergy shots require a lengthy course, typically lasting three to five years, tailored to the allergy type and severity. Many patients discontinue due to treatment duration, age, health, location, and financial constraints, hindering industry growth. Furthermore, the market size is shrinking due to the adverse effects of allergy pills and injections.

  • For instance, a 2022 study published in Human Vaccines & Immunotherapeutics reported that over 10% of patients experienced adverse reactions, including mild to severe local symptoms like oral pruritus (25%), throat discomfort (21%), and mild systemic effects like edema or redness at injection sites.

“High Cost of Treatment Coupled with Poor Patient Adherence”

Allergy shots provide numerous benefits, yet patient adherence to treatment is often insufficient due to factors such as limited patient awareness and inadequate funding.

  • For instance, a 2022 NCBI paper highlights that discomfort associated with subcutaneous (SCIT) and sublingual treatments, along with side effects, are primary reasons for treatment discontinuation.

High cost of treatment and lack of insurance coverage in some countries are expected to restrict the accessibility of allergy shots.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Country-wise Insights

The market in South Korea is forecasted to expand at a CAGR of 6.2% from 2024 to 2034. The country is set to hold 25.2% of the East Asia allergy shot market share by the end of 2034.

What Makes the United States an Attractive Market for Allergy Shot Manufacturers?

“Advanced Clinical Trials and Huge Investments by Corporates”

Attribute United States
Market Value (2024E) US$ 605 Million
Growth Rate (2024 to 2034) 6.5% CAGR
Projected Value (2034F) US$ 1.14 Billion

Firms in the United States are increasing their spending on developing cutting-edge products that are user-friendly and offer quick results. This is one of the key allergy shot market trends in the country.

  • Moonlight Therapeutics, Inc., a biotechnology company investigating therapeutics for food allergies, reported in 2021 that it had received US$ 1.9 million in investment for preclinical studies and product development. This was done to get ready for a clinical trial for the company's principal program in peanut allergy. This financing was made possible by a Phase 2 Small Business grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH).

Why are Market Players Flocking China for Future Business Prospects?

“Government Reforms Supporting Access to Quality Healthcare”

Attribute China
Segment Value (2024E) US$ 217 Million
Growth Rate (2024 to 2034) 7.6%CAGR
Projected Value (2034F) US$ 454 Million

China's population is experiencing a significant increase in allergic conditions, driven by urbanization, changing lifestyles, and environmental factors. This rising prevalence of allergies creates a growing demand for effective treatments like allergy shots. The Chinese government has formulated healthcare reforms to enhance access to quality medical services across the country. This supportive regulatory environment encourages market players to invest in innovative allergy treatments

Category-wise Evaluation

Based on product type, sales of odactra are forecast to rise at a CAGR of 5.4% from 2024 to 2034.

Which Type of Immunotherapy Has Gained Prominence in the Market?

“Growing Demand for Subcutaneous Immunotherapy”

Attribute Subcutaneous Immunotherapy
Segment Value (2024E) US$ 952 Million
Growth Rate (2024 to 2034) 6.1% CAGR
Projected Value (2034F) US$ 1.72 Billion

Allergen-specific subcutaneous immunotherapy effectively treats various allergy disorders. The optimal injection site is the mid-posterolateral region of the upper arm. Subcutaneous immunotherapy (SCIT) represents an innovative approach to managing allergic conditions by modifying the underlying immunological mechanisms, thereby reducing symptoms. Its effectiveness and safety in treating stinging insect hypersensitivity, asthma, and allergic rhinitis/rhino-conjunctivitis have been validated in numerous controlled clinical studies.

What is the Main Reason Behind Global Increase in Allergic Rhinitis Cases?

“Rise in Urbanization and Environmental Pollutants”

Attribute Allergic Rhinitis
Segment Value (2024E) US$ 784 Million
Growth Rate (2024 to 2034) 6% CAGR
Projected Value (2034F) US$ 1.41 Billion

Allergy, also referred to as hay fever or allergic rhinitis, is primarily driven by the global increase in allergic rhinitis cases.

  • According to a 2022 article in Frontiers of Medicine, approximately 400 million people worldwide suffer from allergic rhinitis (AR), making it a significant global health concern.

The prevalence of AR has risen alongside increasing urbanization and environmental pollutants, which are major contributing factors to this condition's growth over time.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Competitive Landscape

Through expansion, collaborations, new product development, mergers and acquisitions, and other growth tactics, key players in the allergy shot market are adapting themselves to the evolving market trends.

  • In October 2023, Itulatek's phase 3 experiment for the treatment of allergic rhino-conjunctivitis brought on by tree pollen was completed, according to ALK.
  • In January 2023, HollisterStier Allergy introduced Ultrafiltered Dog, their newest product innovation, to the allergy market. Patients who are sensitive to dogs respond well to the product's diagnosis and therapy.
  • In October 2022, Aimmune Therapeutics and Allergy Partners, a specialized allergy practice group, partnered to provide Palforzia, an oral immunotherapy, to patients directly.

Fact.MR provides detailed information about the price points of key allergy shot manufacturers positioned across the world, sales growth, production capacity, and speculative technological expansion, in this updated market report.

Key Segments of Allergy Shot Market Research

  • By Product :

    • SLIT Tablets
      • Odactra
      • Grastek
      • Ragwitek
      • Oralair
      • Actair
      • Others
    • Oral
      • Palforzia
      • Others
    • Injections
    • Others
  • By Immunotherapy :

    • Sublingual Immunotherapy (SLIT)
    • Subcutaneous Immunotherapy (SCIT)
    • Specific Immunotherapy
    • Others
  • By Indication :

    • Allergy Rhinitis
    • Allergic Asthma
    • Food Allergy
    • Atopic Dermatitis
    • Others
  • By Allergen :

    • Pollen
      • Grass Pollen
      • Weed Pollen
      • Tree Pollen
    • House Dust Mites (HDMs)
    • Mold
    • Animal Dander
    • Bee Venom
    • Cockroaches/Insects
    • Others
  • By Distribution Channel :

    • Institutional Sales
      • Government Hospitals
      • Semi-Government Hospitals
      • Private Hospitals
    • Retail Sales
      • Retail Pharmacy
      • Drug Stores
      • Online Pharmacy
  • By Region :

    • North America
    • Latin America
    • Eastern Europe
    • Western Europe
    • East Asia
    • South Asia & Pacific
    • Middle East & Africa

Table of Content

  • 1. Executive Summary
  • 2. Industry Introduction, including Taxonomy and Market Definition
  • 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
  • 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
  • 5. Pricing Analysis
  • 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
    • 6.1. Immunotherapy
    • 6.2. Product
    • 6.3. Indication
    • 6.4. Allergen
    • 6.5. Distribution Channel
  • 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Immunotherapy
    • 7.1. Sublingual Immunotherapy (SLIT)
    • 7.2. Subcutaneous Immunotherapy (SCIT)
    • 7.3. Specific Immunotherapy
    • 7.4. Others
  • 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Product
    • 8.1. SLIT Tablets
    • 8.2. Oral
    • 8.3. Injections
    • 8.4. Others
  • 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Indication
    • 9.1. Allergy Rhinitis
    • 9.2. Allergic Asthma
    • 9.3. Food Allergy
    • 9.4. Atopic Dermatitis
    • 9.5. Others
  • 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Allergen
    • 10.1. Pollen
    • 10.2. House Dust Mites (HDMs)
    • 10.3. Mold
    • 10.4. Animal Dander
    • 10.5. Bee Venom
    • 10.6. Cockroaches/Insects
    • 10.7. Others
  • 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Distribution Channel
    • 11.1. Institutional Sales
    • 11.2. Retail Sales
  • 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
    • 12.1. North America
    • 12.2. Latin America
    • 12.3. Western Europe
    • 12.4. Eastern Europe
    • 12.5. East Asia
    • 12.6. South Asia & Pacific
    • 12.7. Middle East & Africa
  • 13. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
  • 14. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
  • 15. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
  • 16. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
  • 17. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
  • 18. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
  • 19. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
  • 20. Sales Forecast 2024 to 2034 by Immunotherapy, Product, Indication, Allergen, Distribution Channel, and Region for 30 Countries
  • 21. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
  • 22. Company Profile
    • 22.1. Circassia
    • 22.2. Merck
    • 22.3. Allergy Therapeutics
    • 22.4. ALK-Abello
    • 22.5. Letipharma
    • 22.6. HollisterStier Allergy
    • 22.7. Aimmune Therapeutics
    • 22.8. DBV Technologies
    • 22.9. Stallergenes Greer
    • 22.10. HAL Allergy Group
    • 22.11. Biomay AG
  • 23. Assumptions and Acronyms Used
  • 24. Research Methodology

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 01: Global Market Value (US$ Mn) Analysis, by Immunotherapy, 2019 to 2023

Table 02: Global Market Value (US$ Mn) Analysis, by Immunotherapy, 2024 to 2034

Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Immunotherapy, 2024 to 2034

Table 04: Global Market Value (US$ Mn) Analysis, by Product, 2019 to 2023

Table 05: Global Market Value (US$ Mn) Analysis, by Product, 2024 to 2034

Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034

Table 07: Global Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023

Table 08: Global Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034

Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034

Table 10: Global Market Value (US$ Mn) Analysis, by Allergen, 2019 to 2023

Table 11: Global Market Value (US$ Mn) Analysis, by Allergen, 2024 to 2034

Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Allergen, 2024 to 2034

Table 13: Global Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023

Table 14: Global Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034

Table 15: Global Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034

Table 16: Global Market Value (US$ Mn) Analysis, by Region, 2019 to 2023

Table 17: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034

Table 18: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034

Table 19: North America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023

Table 20: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 22: North America Market Value (US$ Mn) Analysis, by Immunotherapy, 2019 to 2023

Table 23: North America Market Value (US$ Mn) Analysis, by Immunotherapy, 2024 to 2034

Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Immunotherapy, 2024 to 2034

Table 25: North America Market Value (US$ Mn) Analysis, by Product, 2019 to 2023

Table 26: North America Market Value (US$ Mn) Analysis, by Product, 2024 to 2034

Table 27: North America Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034

Table 28: North America Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023

Table 29: North America Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034

Table 30: North America Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034

Table 31: North America Market Value (US$ Mn) Analysis, by Allergen, 2019 to 2023

Table 32: North America Market Value (US$ Mn) Analysis, by Allergen, 2024 to 2034

Table 33: North America Market Value (US$ Mn) Opportunity Analysis, by Allergen, 2024 to 2034

Table 34: North America Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023

Table 35: North America Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034

Table 36: North America Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034

Table 37: Latin America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023

Table 38: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 39: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 40: Latin America Market Value (US$ Mn) Analysis, by Immunotherapy, 2019 to 2023

Table 41: Latin America Market Value (US$ Mn) Analysis, by Immunotherapy, 2024 to 2034

Table 42: Latin America Market Value (US$ Mn) Opportunity Analysis, by Immunotherapy, 2024 to 2034

Table 43: Latin America Market Value (US$ Mn) Analysis, by Product, 2019 to 2023

Table 44: Latin America Market Value (US$ Mn) Analysis, by Product, 2024 to 2034

Table 45: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034

Table 46: Latin America Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023

Table 47: Latin America Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034

Table 48: Latin America Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034

Table 49: Latin America Market Value (US$ Mn) Analysis, by Allergen, 2019 to 2023

Table 50: Latin America Market Value (US$ Mn) Analysis, by Allergen, 2024 to 2034

Table 51: Latin America Market Value (US$ Mn) Opportunity Analysis, by Allergen, 2024 to 2034

Table 52: Latin America Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023

Table 53: Latin America Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034

Table 54: Latin America Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034

Table 55: Western Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023

Table 56: Western Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 57: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 58: Western Europe Market Value (US$ Mn) Analysis, by Immunotherapy, 2019 to 2023

Table 59: Western Europe Market Value (US$ Mn) Analysis, by Immunotherapy, 2024 to 2034

Table 60: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Immunotherapy, 2024 to 2034

Table 61: Western Europe Market Value (US$ Mn) Analysis, by Product, 2019 to 2023

Table 62: Western Europe Market Value (US$ Mn) Analysis, by Product, 2024 to 2034

Table 63: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034

Table 64: Western Europe Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023

Table 65: Western Europe Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034

Table 66: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034

Table 67: Western Europe Market Value (US$ Mn) Analysis, by Allergen, 2019 to 2023

Table 68: Western Europe Market Value (US$ Mn) Analysis, by Allergen, 2024 to 2034

Table 69: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Allergen, 2024 to 2034

Table 70: Western Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023

Table 71: Western Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034

Table 72: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034

Table 73: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023

Table 74: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 75: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 76: Eastern Europe Market Value (US$ Mn) Analysis, by Immunotherapy, 2019 to 2023

Table 77: Eastern Europe Market Value (US$ Mn) Analysis, by Immunotherapy, 2024 to 2034

Table 78: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Immunotherapy, 2024 to 2034

Table 79: Eastern Europe Market Value (US$ Mn) Analysis, by Product, 2019 to 2023

Table 80: Eastern Europe Market Value (US$ Mn) Analysis, by Product, 2024 to 2034

Table 81: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034

Table 82: Eastern Europe Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023

Table 83: Eastern Europe Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034

Table 84: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034

Table 85: Eastern Europe Market Value (US$ Mn) Analysis, by Allergen, 2019 to 2023

Table 86: Eastern Europe Market Value (US$ Mn) Analysis, by Allergen, 2024 to 2034

Table 87: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Allergen, 2024 to 2034

Table 88: Eastern Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023

Table 89: Eastern Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034

Table 90: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034

Table 91: East Asia Market Value (US$ Mn) Analysis, by Country, 2019 to 2023

Table 92: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 93: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 94: East Asia Market Value (US$ Mn) Analysis, by Immunotherapy, 2019 to 2023

Table 95: East Asia Market Value (US$ Mn) Analysis, by Immunotherapy, 2024 to 2034

Table 96: East Asia Market Value (US$ Mn) Opportunity Analysis, by Immunotherapy, 2024 to 2034

Table 97: East Asia Market Value (US$ Mn) Analysis, by Product, 2019 to 2023

Table 98: East Asia Market Value (US$ Mn) Analysis, by Product, 2024 to 2034

Table 99: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034

Table 100: East Asia Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023

Table 101: East Asia Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034

Table 102: East Asia Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034

Table 103: East Asia Market Value (US$ Mn) Analysis, by Allergen, 2019 to 2023

Table 104: East Asia Market Value (US$ Mn) Analysis, by Allergen, 2024 to 2034

Table 105: East Asia Market Value (US$ Mn) Opportunity Analysis, by Allergen, 2024 to 2034

Table 106: East Asia Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023

Table 107: East Asia Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034

Table 108: East Asia Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034

Table 109: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2019 to 2023

Table 110: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 111: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 112: South Asia & Pacific Market Value (US$ Mn) Analysis, by Immunotherapy, 2019 to 2023

Table 113: South Asia & Pacific Market Value (US$ Mn) Analysis, by Immunotherapy, 2024 to 2034

Table 114: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Immunotherapy, 2024 to 2034

Table 115: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product, 2019 to 2023

Table 116: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product, 2024 to 2034

Table 117: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034

Table 118: South Asia & Pacific Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023

Table 119: South Asia & Pacific Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034

Table 120: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034

Table 121: South Asia & Pacific Market Value (US$ Mn) Analysis, by Allergen, 2019 to 2023

Table 122: South Asia & Pacific Market Value (US$ Mn) Analysis, by Allergen, 2024 to 2034

Table 123: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Allergen, 2024 to 2034

Table 124: South Asia & Pacific Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023

Table 125: South Asia & Pacific Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034

Table 126: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034

Table 127: MEA Market Value (US$ Mn) Analysis, by Country, 2019 to 2023

Table 128: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 129: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 130: MEA Market Value (US$ Mn) Analysis, by Immunotherapy, 2019 to 2023

Table 131: MEA Market Value (US$ Mn) Analysis, by Immunotherapy, 2024 to 2034

Table 132: MEA Market Value (US$ Mn) Opportunity Analysis, by Immunotherapy, 2024 to 2034

Table 133: MEA Market Value (US$ Mn) Analysis, by Product, 2019 to 2023

Table 134: MEA Market Value (US$ Mn) Analysis, by Product, 2024 to 2034

Table 135: MEA Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034

Table 136: MEA Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023

Table 137: MEA Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034

Table 138: MEA Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034

Table 139: MEA Market Value (US$ Mn) Analysis, by Allergen, 2019 to 2023

Table 140: MEA Market Value (US$ Mn) Analysis, by Allergen, 2024 to 2034

Table 141: MEA Market Value (US$ Mn) Opportunity Analysis, by Allergen, 2024 to 2034

Table 142: MEA Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023

Table 143: MEA Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034

Table 144: MEA Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2019 to 2023

Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2019 to 2034

Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034

Figure 05: Global Market Share and BPS Analysis by Immunotherapy, 2024 & 2034

Figure 06: Global Market Y-o-Y Growth Projections by Immunotherapy, 2024 to 2034

Figure 07: Global Market Attractiveness Analysis by Immunotherapy, 2024 to 2034

Figure 08: Global Market Share and BPS Analysis by Product, 2024 & 2034

Figure 09: Global Market Y-o-Y Growth Projections by Product, 2024 to 2034

Figure 10: Global Market Attractiveness Analysis by Product, 2024 to 2034

Figure 11: Global Market Share and BPS Analysis by Indication, 2024 & 2034

Figure 12: Global Market Y-o-Y Growth Projections by Indication, 2024 to 2034

Figure 13: Global Market Attractiveness Analysis by Indication, 2024 to 2034

Figure 14: Global Market Share and BPS Analysis by Allergen, 2024 & 2034

Figure 15: Global Market Y-o-Y Growth Projections by Allergen, 2024 to 2034

Figure 16: Global Market Attractiveness Analysis by Allergen, 2024 to 2034

Figure 17: Global Market Share and BPS Analysis by Distribution Channel, 2024 & 2034

Figure 18: Global Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034

Figure 19: Global Market Attractiveness Analysis by Distribution Channel, 2024 to 2034

Figure 20: Global Market Share and BPS Analysis by Region, 2024 & 2034

Figure 21: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034

Figure 22: Global Market Attractiveness Analysis by Region, 2024 to 2034

Figure 23: North America Market Value (US$ Mn) Historical Analysis, 2019 to 2023

Figure 24: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 25: North America Market Value Y-o-Y Growth and Forecast, 2034

Figure 26: North America Market Incremental $ Opportunity, 2024 to 2034

Figure 27: North America Market Share Analysis by Country, 2024 & 2034

Figure 28: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 29: North America Market Attractiveness Analysis by Country, 2024 to 2034

Figure 30: North America Market Share and BPS Analysis by Immunotherapy, 2024 & 2034

Figure 31: North America Market Y-o-Y Growth Projections by Immunotherapy, 2024 to 2034

Figure 32: North America Market Attractiveness Analysis by Immunotherapy, 2024 to 2034

Figure 33: North America Market Share and BPS Analysis by Product, 2024 & 2034

Figure 34: North America Market Y-o-Y Growth Projections by Product, 2024 to 2034

Figure 35: North America Market Attractiveness Analysis by Product, 2024 to 2034

Figure 36: North America Market Share and BPS Analysis by Indication, 2024 & 2034

Figure 37: North America Market Y-o-Y Growth Projections by Indication, 2024 to 2034

Figure 38: North America Market Attractiveness Analysis by Indication, 2024 to 2034

Figure 39: North America Market Share and BPS Analysis by Allergen, 2024 & 2034

Figure 40: North America Market Y-o-Y Growth Projections by Allergen, 2024 to 2034

Figure 41: North America Market Attractiveness Analysis by Allergen, 2024 to 2034

Figure 42: North America Market Share and BPS Analysis by Distribution Channel, 2024 & 2034

Figure 43: North America Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034

Figure 44: North America Market Attractiveness Analysis by Distribution Channel, 2024 to 2034

Figure 45: Latin America Market Value (US$ Mn) Historical Analysis, 2019 to 2023

Figure 46: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 47: Latin America Market Value Y-o-Y Growth and Forecast, 2019 to 2034

Figure 48: Latin America Market Incremental $ Opportunity, 2024 to 2034

Figure 49: Latin America Market Share Analysis by Country, 2024 & 2034

Figure 50: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 51: Latin America Market Attractiveness Analysis by Country, 2024 to 2034

Figure 52: Latin America Market Share and BPS Analysis by Immunotherapy, 2024 & 2034

Figure 53: Latin America Market Y-o-Y Growth Projections by Immunotherapy, 2024 to 2034

Figure 54: Latin America Market Attractiveness Analysis by Immunotherapy, 2024 to 2034

Figure 55: Latin America Market Share and BPS Analysis by Product, 2024 & 2034

Figure 56: Latin America Market Y-o-Y Growth Projections by Product, 2024 to 2034

Figure 57: Latin America Market Attractiveness Analysis by Product, 2024 to 2034

Figure 58: Latin America Market Share and BPS Analysis by Indication, 2024 & 2034

Figure 59: Latin America Market Y-o-Y Growth Projections by Indication, 2024 to 2034

Figure 60: Latin America Market Attractiveness Analysis by Indication, 2024 to 2034

Figure 61: Latin America Market Share and BPS Analysis by Allergen, 2024 & 2034

Figure 62: Latin America Market Y-o-Y Growth Projections by Allergen, 2024 to 2034

Figure 63: Latin America Market Attractiveness Analysis by Allergen, 2024 to 2034

Figure 64: Latin America Market Share and BPS Analysis by Distribution Channel, 2024 & 2034

Figure 65: Latin America Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034

Figure 66: Latin America Market Attractiveness Analysis by Distribution Channel, 2024 to 2034

Figure 67: Western Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023

Figure 68: Western Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 69: Western Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034

Figure 70: Western Europe Market Incremental $ Opportunity, 2024 to 2034

Figure 71: Western Europe Market Share Analysis by Country, 2024 & 2034

Figure 72: Western Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 73: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034

Figure 74: Western Europe Market Share and BPS Analysis by Immunotherapy, 2024 & 2034

Figure 75: Western Europe Market Y-o-Y Growth Projections by Immunotherapy, 2024 to 2034

Figure 76: Western Europe Market Attractiveness Analysis by Immunotherapy, 2024 to 2034

Figure 77: Western Europe Market Share and BPS Analysis by Product, 2024 & 2034

Figure 78: Western Europe Market Y-o-Y Growth Projections by Product, 2024 to 2034

Figure 79: Western Europe Market Attractiveness Analysis by Product, 2024 to 2034

Figure 80: Western Europe Market Share and BPS Analysis by Indication, 2024 & 2034

Figure 81: Western Europe Market Y-o-Y Growth Projections by Indication, 2024 to 2034

Figure 82: Western Europe Market Attractiveness Analysis by Indication, 2024 to 2034

Figure 83: Western Europe Market Share and BPS Analysis by Allergen, 2024 & 2034

Figure 84: Western Europe Market Y-o-Y Growth Projections by Allergen, 2024 to 2034

Figure 85: Western Europe Market Attractiveness Analysis by Allergen, 2024 to 2034

Figure 86: Western Europe Market Share and BPS Analysis by Distribution Channel, 2024 & 2034

Figure 87: Western Europe Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034

Figure 88: Western Europe Market Attractiveness Analysis by Distribution Channel, 2024 to 2034

Figure 89: Eastern Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023

Figure 90: Eastern Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 91: Eastern Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034

Figure 92: Eastern Europe Market Incremental $ Opportunity, 2024 to 2034

Figure 93: Eastern Europe Market Share Analysis by Country, 2024 & 2034

Figure 94: Eastern Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 95: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034

Figure 96: Eastern Europe Market Share and BPS Analysis by Immunotherapy, 2024 & 2034

Figure 97: Eastern Europe Market Y-o-Y Growth Projections by Immunotherapy, 2024 to 2034

Figure 98: Eastern Europe Market Attractiveness Analysis by Immunotherapy, 2024 to 2034

Figure 99: Eastern Europe Market Share and BPS Analysis by Product, 2024 & 2034

Figure 100: Eastern Europe Market Y-o-Y Growth Projections by Product, 2024 to 2034

Figure 101: Eastern Europe Market Attractiveness Analysis by Product, 2024 to 2034

Figure 102: Eastern Europe Market Share and BPS Analysis by Indication, 2024 & 2034

Figure 103: Eastern Europe Market Y-o-Y Growth Projections by Indication, 2024 to 2034

Figure 104: Eastern Europe Market Attractiveness Analysis by Indication, 2024 to 2034

Figure 105: Eastern Europe Market Share and BPS Analysis by Allergen, 2024 & 2034

Figure 106: Eastern Europe Market Y-o-Y Growth Projections by Allergen, 2024 to 2034

Figure 107: Eastern Europe Market Attractiveness Analysis by Allergen, 2024 to 2034

Figure 108: Eastern Europe Market Share and BPS Analysis by Distribution Channel, 2024 & 2034

Figure 109: Eastern Europe Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034

Figure 110: Eastern Europe Market Attractiveness Analysis by Distribution Channel, 2024 to 2034

Figure 111: East Asia Market Value (US$ Mn) Historical Analysis, 2019 to 2023

Figure 112: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 113: East Asia Market Value Y-o-Y Growth and Forecast, 2019 to 2034

Figure 114: East Asia Market Incremental $ Opportunity, 2024 to 2034

Figure 115: East Asia Market Share Analysis by Country, 2024 & 2034

Figure 116: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 117: East Asia Market Attractiveness Analysis by Country, 2024 to 2034

Figure 118: East Asia Market Share and BPS Analysis by Immunotherapy, 2024 & 2034

Figure 119: East Asia Market Y-o-Y Growth Projections by Immunotherapy, 2024 to 2034

Figure 120: East Asia Market Attractiveness Analysis by Immunotherapy, 2024 to 2034

Figure 121: East Asia Market Share and BPS Analysis by Product, 2024 & 2034

Figure 122: East Asia Market Y-o-Y Growth Projections by Product, 2024 to 2034

Figure 123: East Asia Market Attractiveness Analysis by Product, 2024 to 2034

Figure 124: East Asia Market Share and BPS Analysis by Indication, 2024 & 2034

Figure 125: East Asia Market Y-o-Y Growth Projections by Indication, 2024 to 2034

Figure 126: East Asia Market Attractiveness Analysis by Indication, 2024 to 2034

Figure 127: East Asia Market Share and BPS Analysis by Allergen, 2024 & 2034

Figure 128: East Asia Market Y-o-Y Growth Projections by Allergen, 2024 to 2034

Figure 129: East Asia Market Attractiveness Analysis by Allergen, 2024 to 2034

Figure 130: East Asia Market Share and BPS Analysis by Distribution Channel, 2024 & 2034

Figure 131: East Asia Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034

Figure 132: East Asia Market Attractiveness Analysis by Distribution Channel, 2024 to 2034

Figure 133: South Asia & Pacific Market Value (US$ Mn) Historical Analysis, 2019 to 2023

Figure 134: South Asia & Pacific Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 135: South Asia & Pacific Market Value Y-o-Y Growth and Forecast, 2019 to 2034

Figure 136: South Asia & Pacific Market Incremental $ Opportunity, 2024 to 2034

Figure 137: South Asia & Pacific Market Share Analysis by Country, 2024 & 2034

Figure 138: South Asia & Pacific Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 139: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034

Figure 140: South Asia & Pacific Market Share and BPS Analysis by Immunotherapy, 2024 & 2034

Figure 141: South Asia & Pacific Market Y-o-Y Growth Projections by Immunotherapy, 2024 to 2034

Figure 142: South Asia & Pacific Market Attractiveness Analysis by Immunotherapy, 2024 to 2034

Figure 143: South Asia & Pacific Market Share and BPS Analysis by Product, 2024 & 2034

Figure 144: South Asia & Pacific Market Y-o-Y Growth Projections by Product, 2024 to 2034

Figure 145: South Asia & Pacific Market Attractiveness Analysis by Product, 2024 to 2034

Figure 146: South Asia & Pacific Market Share and BPS Analysis by Indication, 2024 & 2034

Figure 147: South Asia & Pacific Market Y-o-Y Growth Projections by Indication, 2024 to 2034

Figure 148: South Asia & Pacific Market Attractiveness Analysis by Indication, 2024 to 2034

Figure 149: South Asia & Pacific Market Share and BPS Analysis by Allergen, 2024 & 2034

Figure 150: South Asia & Pacific Market Y-o-Y Growth Projections by Allergen, 2024 to 2034

Figure 151: South Asia & Pacific Market Attractiveness Analysis by Allergen, 2024 to 2034

Figure 152: South Asia & Pacific Market Share and BPS Analysis by Distribution Channel, 2024 & 2034

Figure 153: South Asia & Pacific Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034

Figure 154: South Asia & Pacific Market Attractiveness Analysis by Distribution Channel, 2024 to 2034

Figure 155: MEA Market Value (US$ Mn) Historical Analysis, 2019 to 2023

Figure 156: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 157: MEA Market Value Y-o-Y Growth and Forecast, 2019 to 2034

Figure 158: MEA Market Incremental $ Opportunity, 2024 to 2034

Figure 159: MEA Market Share Analysis by Country, 2024 & 2034

Figure 160: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 161: MEA Market Attractiveness Analysis by Country, 2024 to 2034

Figure 162: MEA Market Share and BPS Analysis by Immunotherapy, 2024 & 2034

Figure 163: MEA Market Y-o-Y Growth Projections by Immunotherapy, 2024 to 2034

Figure 164: MEA Market Attractiveness Analysis by Immunotherapy, 2024 to 2034

Figure 165: MEA Market Share and BPS Analysis by Product, 2024 & 2034

Figure 166: MEA Market Y-o-Y Growth Projections by Product, 2024 to 2034

Figure 167: MEA Market Attractiveness Analysis by Product, 2024 to 2034

Figure 168: MEA Market Share and BPS Analysis by Indication, 2024 & 2034

Figure 169: MEA Market Y-o-Y Growth Projections by Indication, 2024 to 2034

Figure 170: MEA Market Attractiveness Analysis by Indication, 2024 to 2034

Figure 171: MEA Market Share and BPS Analysis by Allergen, 2024 & 2034

Figure 172: MEA Market Y-o-Y Growth Projections by Allergen, 2024 to 2034

Figure 173: MEA Market Attractiveness Analysis by Allergen, 2024 to 2034

Figure 174: MEA Market Share and BPS Analysis by Distribution Channel, 2024 & 2034

Figure 175: MEA Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034

Figure 176: MEA Market Attractiveness Analysis by Distribution Channel, 2024 to 2034

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

- FAQs -

How big is the allergy shot market in 2024?

The global market for allergen shots is estimated at US$ 1.84 billion in 2024.

What is the demand outlook for allergy shots by 2034?

Global sales for allergy shots are forecasted to reach US$ 3.34 billion by 2034.

At what rate are the sales for allergy shots projected to rise?

The allergy shot market is forecasted to expand at a CAGR of 6.1% from 2024 to 2034.

How much share of global market revenue is North America evaluated to hold?

North America is forecasted to hold 40.3% share of the global market by 2034.

At what CAGR is the demand for allergy shots evaluated to accelerate in Japan?

The market in Japan is projected to increase at 5.6% CAGR from 2024 to 2034.

What is the contribution of subcutaneous immunotherapy to global market revenue?

The subcutaneous immunotherapy segment is projected to account for 51.7% share of global market revenue by 2034.

Who are the prominent manufacturers of allergy shots?

Some of the leading market players are Circassia, Merck, Allergy Therapeutics, and ALK-Abello.

- Also of Interest -

OTC Cough, Cold and Allergy Medicine Market

OTC Cough, Cold and Allergy Medicine Market Forecast by Drug Type (Antihistamine, Expectorants, Bronchodilators, and Antibiotics), by OTC Channel (Pharmacies, Drug Store, Modern Trade Online Sales), by Dosage (Capsules, Liquid, Lozenges), by Application, and by Region - 2022 to 2032

Respiratory Virus Vaccines Market

Respiratory Virus Vaccines Market Analysis by Inactivated/Killed, Live-attenuated, and Recombinant for Influenza, Measles, Mumps, & Rubella, and Coronavirus Disease (COVID-19) from 2023 to 2033

Allergic Rhinitis Treatment Market

Allergic Rhinitis Treatment Market Analysis by Anti-histamines, Decongestants, and Corticosteroids, Immunotherapy (SCIT, SLITD, SLITT) for Hospital, Retail, and Online Pharmacies from 2024 to 2034

Allergy Care Market

Allergy Care Market by Allergy Type (Eye Allergy, Skin Allergy, Food Allergy), by Product Type (Nasal Spray, Antihistamine Medication, Eye Drops), by Form (Tablet/Gels/Pills, Sprays, Liquids), by Sales Channel, & by Region - Global Insights 2022 to 2032

Allergy Shot Market

Schedule a Call